MTM(SH:688029) Sou Hu Cai Jing·2025-07-29 11:04Group 1 - The core viewpoint of the articles highlights that Nanwei Medical's stock closed at 84.08 yuan, with a decline of 1.27%, and a rolling PE ratio of 27.68 times, while the total market capitalization is 15.794 billion yuan [1] - The average PE ratio for the medical device industry is 55.46 times, with a median of 37.74 times, placing Nanwei Medical at the 55th position in the industry ranking [1] - As of the first quarter of 2025, 17 institutions hold shares in Nanwei Medical, with a total of 5.4605 million shares valued at 369 million yuan [1] Group 2 - Nanwei Medical specializes in the research, manufacturing, and sales of minimally invasive medical devices, with key products including biopsy, hemostasis, closure devices, EMR/ESD devices, dilation devices, ERCP devices, EUS/EBUS devices, ablation instruments, disposable imaging systems, and related consumables [1] - The latest financial report for the first quarter of 2025 shows that the company achieved an operating income of 699 million yuan, representing a year-on-year increase of 12.75%, and a net profit of 161 million yuan, also up by 12.18%, with a gross profit margin of 65.69% [1]